A Villegas

Author PubWeight™ 46.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Healing of broken human chromosomes by the addition of telomeric repeats. Am J Hum Genet 1994 1.69
2 Strong association of socioeconomic status with genetic ancestry in Latinos: implications for admixture studies of type 2 diabetes. Diabetologia 2009 1.69
3 Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group. Haematologica 1999 1.48
4 [HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis]. Rev Esp Enferm Dig 2003 1.46
5 Beta-thalassaemia in south-western Spain: high frequency of G-->A (IVS I-1) mutation. Br J Haematol 1996 1.40
6 Rearrangement of the BCR/ABL and TCR-beta genes in lymph node blast crisis diagnosed of chronic myeloid leukemia. Am J Hematol 1994 1.39
7 [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia]. Med Clin (Barc) 1993 1.38
8 [The relationship between the persistence of the BCR/ABL gene and relapse in adult patients with acute lymphoblastic leukemia]. Med Clin (Barc) 1999 1.38
9 Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification. Ann Hematol 2012 1.28
10 Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effects. Eur J Hum Genet 2001 1.12
11 C455R notch3 mutation in a Colombian CADASIL kindred with early onset of stroke. Neurology 2002 1.05
12 Haemoglobinopathies with high oxygen affinity. Experience of Erythropathology Cooperative Spanish Group. Ann Hematol 2008 0.92
13 [Epidemiologic monitoring and decentralized planification: the use of sentinel sites in Guerrero]. Salud Publica Mex 1990 0.88
14 Transcobalamin II deficiency: long-term follow-up of two cases. Acta Haematol 1988 0.88
15 Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols. Haematologica 2001 0.88
16 A family of novel myb-related genes from the resurrection plant Craterostigma plantagineum are specifically expressed in callus and roots in response to ABA or desiccation. Plant Mol Biol 1996 0.86
17 Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status. Int J Hematol 2008 0.84
18 C-->T mutation at -158 G gamma HPFH associated with 4 bp deletion (-225-222) in the promoter region of the A gamma gene in homozygous beta 0 39 nonsense thalassemia. Haematologica 1999 0.84
19 Identification of the Hb Lepore phenotype by HPLC. Haematologica 1999 0.84
20 [Molecular analysis of glucose-6-dehydrogenase deficiency in Spain]. Sangre (Barc) 1997 0.83
21 A novel splice acceptor site mutation of the alpha2-globin gene causing alpha-thalassemia. Hemoglobin 2001 0.83
22 Acute promyelocytic leukemia relapse in the central nervous system during hematologic and molecular remission. Am J Hematol 1999 0.82
23 Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus. Am J Med 2001 0.81
24 Hb Johnstown [beta 109 (G11) Val-->Leu]: second case described and associated for the first time with beta(0)-thalassemia in two Spanish families. Am J Hematol 2000 0.81
25 Hb Shepherds Bush [beta 74(E18)Gly-->Asp]: the first case in a Spanish woman. Hemoglobin 1993 0.81
26 Homozygous Constant Spring: the first case described in the west. Haematologica 2000 0.80
27 Response of the haematocrit to body condition changes in Northern Bald Ibis Geronticus eremita. Comp Biochem Physiol A Mol Integr Physiol 2004 0.80
28 Characterization of chromosomes with hybrid genes for Hb Lepore-Washington, Hb Lepore-Baltimore, Hb P-Nilotic, and Hb Kenya. Hum Genet 1987 0.80
29 Translocation (9;22;21) in a chronic myeloid leukemia fluorescence in situ hybridization definition. Cancer Genet Cytogenet 1998 0.79
30 Chromosomal disorder and neoplastic diseases in a family with inherited fragile 16. Causality or casualty? Cancer Genet Cytogenet 1994 0.79
31 TEL/AML1 transcript and p16 gene deletion in a patient with childhood acute lymphoblastic leukaemia. Br J Haematol 1997 0.79
32 Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia. Br J Haematol 1993 0.79
33 Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group. Br J Haematol 2001 0.78
34 Effect of age and severity of cognitive dysfunction on spontaneous activity in pet dogs - part 1: locomotor and exploratory behaviour. Vet J 2012 0.78
35 Autotransplantation of peripheral blood stem cells mobilized by G-CSF in hematological malignancies: evidence for rapid and long-term sustained hematopoietic reconstitution. Leuk Lymphoma 1996 0.78
36 Antibody-independent inhibition of Plasmodium falciparum in vitro cultures. J Clin Microbiol 1990 0.78
37 Intragraft cytokine expression in heart transplants with mild or no histological rejection. Clin Transplant 2001 0.78
38 Endohelminth parasites from salmonids in intensive culture from southern Chile. J Parasitol 2010 0.77
39 Effect of fluoxetine on blood concentrations of serotonin, cortisol and dehydroepiandrosterone in canine aggression. J Vet Pharmacol Ther 2010 0.76
40 A mutation in the polyadenylation signal of the alpha 2 globin gene (AATAAA-->AATA--) as a cause of alpha thalassaemia in Asian indians. Br J Haematol 1994 0.76
41 Characterization of a new hemoglobin variant: Hb Badalona (beta31[B13]Leu-->Val). Ann Hematol 2002 0.76
42 Effect of age and severity of cognitive dysfunction on spontaneous activity in pet dogs - part 2: social responsiveness. Vet J 2012 0.76
43 Effect of age and severity of cognitive dysfunction on two simple tasks in pet dogs. Vet J 2013 0.76
44 Late relapse in BCR/ABL-positive patients after non-intensive chemotherapy. Leukemia 1998 0.75
45 Fungal endocarditis caused by Arnium leporinum following cardiac surgery. Sabouraudia 1984 0.75
46 The importance of molecular screening of 11q23 abnormalities in childhood acute lymphoblastic leukemia: has the t(11;19)(q23;p13) a higher frequency than that revealed by conventional cytogenetic techniques? Med Pediatr Oncol 1998 0.75
47 Nondeletional alpha-thalassemia in a Spanish population. Am J Hematol 1997 0.75
48 Bone marrow necrosis. Am J Hematol 1995 0.75
49 Myelofibrosis in primary myelodysplastic syndromes. Br J Haematol 1989 0.75
50 Lymphoid blastic transformation in chronic myeloid leukemia. Am J Hematol 1994 0.75
51 Frameshift CD 11 (-T) beta-thalassemia mutation. Am J Hematol 1997 0.75
52 Changes in reticulocyte fractions during peripheral stem cell harvesting exclusively mobilized with rhG-CSF. Bone Marrow Transplant 1996 0.75
53 Unusual translocations and other changes in acute leukemia. Cancer Genet Cytogenet 1991 0.75
54 Haemoglobin LeporeBaltimore in a Spanish family. Acta Haematol 1983 0.75
55 Steroid secretion by a lipoid cell tumor causing virilization and its diagnosis with computerized tomography. Am J Obstet Gynecol 1985 0.75
56 Erythrocyte 2,3-diphosphoglycerate in polycythaemias. Scand J Haematol 1982 0.75
57 Polycythaemia and haemoglobin Lepore Boston. An uncommon association. Clin Lab Haematol 1983 0.75
58 [Hemoglobin H disease and refractory anemia]. Sangre (Barc) 1988 0.75
59 [Comparative study of 2 methods of quantifying hemoglobin A2: cellulose acetate electrophoresis with further elution and column microchromatography]. Sangre (Barc) 1986 0.75
60 [Erythroleukemia in the evolution of a Fanconi's constitutional anemia]. Sangre (Barc) 1983 0.75
61 Detection of bcr/abl mRNA in a case of chronic myelogenous leukemia in long-term remission: CML or sensitivity of detection? Haematologica 1998 0.75
62 [Evaluation of stomatological care in Santiago de los Caballeros, Dominican Republic, stage 1]. Educ Med Salud 1986 0.75
63 Fibrinolysis in thoracic surgery. Int Surg 1973 0.75
64 [Sea-blue histiocyte syndrome. Report of a case (author's transl)]. Sangre (Barc) 1978 0.75
65 [Morphology and cytochemistry in the diagnosis of myelodysplastic syndromes]. Sangre (Barc) 1985 0.75
66 Hb J-Baltimore [beta 16(A13)Gly-->Asp] associated with beta(+)-thalassemia in a Spanish family. Hemoglobin 1996 0.75
67 [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols]. Med Clin (Barc) 1989 0.75
68 [Molecular heterogeneity of beta thalassemia]. Sangre (Barc) 1994 0.75
69 [Change in cell line in relapses of acute lymphoid leukemia: frequency, morphologic, phenotypic and cytogenetic characteristics and clinical course]. Med Clin (Barc) 1988 0.75
70 Hb O Padova in a Spanish Family. Acta Haematol 1990 0.75
71 Cytological and cytochemical study of the peripheral blood mononuclear cells in leukapheresis products mobilized with rhG-CSF. Bone Marrow Transplant 1996 0.75
72 [Iron chelators]. Med Clin (Barc) 1994 0.75
73 [Observations of alpha-thalasemia and hemoglobin h in spaniards (author's transl)]. Sangre (Barc) 1979 0.75
74 [Hemoglobin Complutense (beta 127 (H5) Gln replaced by Glu) in a Spanish family]. Sangre (Barc) 1987 0.75
75 [Application of 2 electrophoresis techniques to the analysis of erythrocyte membrane proteins in hereditary spherocytosis]. Sangre (Barc) 1993 0.75
76 [Hemoglobin, carboxyhemoglobin and oxyhemoglobin saturation curves in healthy smokers]. Med Clin (Barc) 1984 0.75
77 [Second neoplasms as a late complication of the treatment of Hodgkin's disease]. Sangre (Barc) 1992 0.75
78 Deletion of BCR region 3' in chronic myelogenous leukemia. Cancer Genet Cytogenet 2001 0.75
79 [Erythroleukosis]. Rev Clin Esp 1978 0.75
80 [Disseminated intravascular coagulation during the course of acute supurative cholecystitis]. Rev Esp Enferm Apar Dig 1977 0.75
81 Thrombosis and severe asthenia as priority manifestations in paroxysmal nocturnal haemoglobinuria. Ann Hematol 2012 0.75
82 [Treatment of the hemolytic-uremic syndrome and thrombotic thrombopenic purpura]. Sangre (Barc) 1983 0.75
83 The first report of a Philadelphia chromosome and BCR/ABL rearrangement positive myeloproliferative disorder in a child with thrombocythemia. Leukemia 1998 0.75
84 Association of t(9;11)-MLL AF9 and trisomy 8 in an AML-M5 preceded by pancytopenia. Cancer Genet Cytogenet 2000 0.75
85 [Functional classification of the lymphoproliferative syndromes (author's transl)]. Sangre (Barc) 1977 0.75
86 Bilateral ureterocystoplasty with solely bladder tube flap. An experimental study in dogs. Urol Int 1973 0.75
87 [High- and low-risk molecular sequences in autoimmune diseases. An analysis of type I diabetes in Latin America]. Gac Med Mex 1997 0.75
88 [Adaptation to anemia in hypothyroidism]. Rev Clin Esp 1981 0.75
89 [Method recommended by the International Committee for Standardization in Hematology for determining fetal hemoglobin]. Sangre (Barc) 1983 0.75
90 Sea-blue histiocytosis. Arch Pathol Lab Med 1980 0.75
91 [Recommended method for the determination of hematocrit values]. Sangre (Barc) 1982 0.75
92 [Bence-Jones' myeloma]. Rev Clin Esp 1976 0.75
93 [The association of beta zero-thalassemia and Hb D Punjab in a family of Indian origin. The second case reported in Spain]. Med Clin (Barc) 1997 0.75
94 [Usefulness of molecular screening in childhood lymphoblastic leukemias]. Sangre (Barc) 1998 0.75
95 Study of the BCR/ABL rearrangement in patients with two Philadelphia chromosomes. Cancer Genet Cytogenet 1993 0.75
96 Relationship of red-cell 2,3-diphosphoglycerate with anaemia, hypoxaemia and acid-base status in patients with cirrhosis of the liver. Scand J Clin Lab Invest 1982 0.75
97 [Cytochemical features of acute non-lymphocytic leukaemias (author's transl)]. Sangre (Barc) 1979 0.75
98 [Methods recommended by the International Committee for Standardization in Hematology for the determination of hemoglobin A2]. Sangre (Barc) 1982 0.75
99 Cleavage of the ALL1 gene in acute lymphoid leukemia before treatment disappears in relapse. Haematologica 1999 0.75
100 [Acquired hemoglobin H disease associated with a myelodysplastic syndrome]. Sangre (Barc) 1994 0.75
101 [The successive presence of acute lymphoblastic leukemia, Hodgkin's disease and acute myeloblastic leukemia in a female patient]. Rev Clin Esp 1991 0.75
102 A case of Hb J-Chicago [beta 76(E20)Ala-->Asp] in a Spanish family. Hemoglobin 1998 0.75
103 [Hemoglobinopathies in the Bahia de Cádiz]. Sangre (Barc) 1995 0.75
104 [Scorpion stings in Guerrero: an epidemiologic study in 20 communities]. Salud Publica Mex 1988 0.75
105 [Hemoglobinopathies in Spanish and emigrant population]. An Med Interna 2006 0.75
106 Red-cell 2,3-diphosphoglycerate in thalassaemia. Haematologica 1983 0.75
107 [Alpha-1 thalassemia trait: 1st minor form of alpha thalassemia diagnosed at birth in Spain]. Med Clin (Barc) 1987 0.75
108 [Megaloblastic anemia caused by a congenital deficiency of transcobalamin II]. Sangre (Barc) 1990 0.75
109 The identification of five rare beta-chain abnormal hemoglobins by high performance liquid chromatographic procedures. Hemoglobin 1986 0.75
110 [Diagnostic value of serum ferritin in anaemias and in iron overload (author's transl)]. Sangre (Barc) 1980 0.75
111 [Probable pathogenic relation between systemic mastocytosis and reflux esophagitis]. Rev Clin Esp 1974 0.75
112 [Impact of delayed discharge for nonmedical reasons in a tertiary hospital internal medicine department]. Rev Clin Esp 2012 0.75
113 [Value of analyzing reticulocyte subpopulations in polycythemia]. Sangre (Barc) 1997 0.75
114 Haemoglobin Presbyterian [beta 108 (G 10) Asn----Lys] in a Spanish family. Acta Haematol 1986 0.75
115 Molecular heterogeneity of beta-thalassaemia in a Spanish population from the area centre of Spain. Eur J Haematol 1996 0.75
116 Is the alpha(-)(cal) mutation prevalent in central Spain? Haematologica 2000 0.75
117 [The first case of beta-thalassemia by frameshift CD5 (-CT) mutation in Spain]. Med Clin (Barc) 1999 0.75
118 [Thymoma. Its clinical diagnosis through the general manifestations]. Rev Clin Esp 1976 0.75
119 Hematologic data in 825 cases of beta-thalassemia trait in Spain. Nouv Rev Fr Hematol 1990 0.75
120 Two new families with HB Hofu discovered in Spain. Haematologica 1988 0.75
121 Intraerythrocytic adaptation to anaemia in thalassaemia. Nouv Rev Fr Hematol 1983 0.75
122 [Free erythrocytic protoporphyrin and thalassemic trait]. Sangre (Barc) 1989 0.75
123 [High-dose chemotherapy with four drugs and peripheral blood progenitor cell autologous transplantation in disseminated breast cancer]. Med Clin (Barc) 1997 0.75
124 Acute myeloid leukemia and erythroleukemia. Ann Intern Med 1986 0.75
125 [Late recurrences in Hodgkin's disease: description of a case after 14 yr of continuous remission]. Sangre (Barc) 1991 0.75
126 [Hemoglobin C in the 1st year of life]. Sangre (Barc) 1995 0.75
127 A comparison of the Lippes Loop, the TCu - 200, and the Dalkon Shield in a single clinic in Colombia. Stud Fam Plann 1975 0.75
128 Congenital dyserythropoietic anemia type III with unbalanced globin chain synthesis. Eur J Haematol 1994 0.75
129 [Spanish family with heterozygous HbS trait]. Rev Clin Esp 1981 0.75
130 [Chromosomal changes in 60 patients with acute myeloblastic leukemia. Frequency, characteristics and prognostic significance]. Sangre (Barc) 1990 0.75
131 [New therapeutic perspectives in iron overload]. An Med Interna 2006 0.75
132 [Splenectomy in the treatment of primary lymphoma of the spleen]. Rev Invest Clin 1986 0.75
133 [Haplotype in 3 patients homozygous for beta-thalassemia]. Sangre (Barc) 1987 0.75
134 [Thrombocytopenias induced by infections]. An Esp Pediatr 1988 0.75
135 [Results of a quality control program in hematology (2d evaluation)]. Sangre (Barc) 1984 0.75
136 [Morphology and cytochemistry of acute leukaemia (author's transl)]. Sangre (Barc) 1981 0.75
137 [The cytochemistry of mononuclear-macrophagic cells]. Sangre (Barc) 1982 0.75
138 Two new mutations in cis on (G)gamma chain of fetal hemoglobin: Hb F-Madrid [G gamma 50(D1)Ser-->Cys] and [G gamma 75(E19)Ile-->Thr]. Ann Hematol 2003 0.75
139 Bcl-2 gene rearrangement: diagnostic implications in a case of a large cell diffuse lymphoma appearing in leukemic phase. Am J Hematol 1995 0.75
140 [Involvement of chromosome 1, associated with t(8;14), in 2 cases of Burkitt's lymphoma and a case of ALL (L3)]. Sangre (Barc) 1988 0.75
141 [Molecular biology in the diagnosis of hematologic diseases]. Rev Clin Esp 1991 0.75
142 [Identification of 5 variants of the hemoglobin beta chain using DNA analysis (amplification, sequencing and restriction enzymes)]. Sangre (Barc) 1997 0.75
143 Comparison of continuation rates of intrauterine devices. Obstet Gynecol 1976 0.75
144 A new family with hereditary choreo-acanthocytosis. Acta Haematol 1987 0.75
145 [PCR study of bcl-2 rearrangement in autologous transplantation of peripheral stem cells in follicular non-Hodgkin's lymphoma]. Med Clin (Barc) 1997 0.75
146 [Erythropoietin and the kidney, with regard to the pathogenesis of the anaemia of chronic renal failure (author's transl)]. Sangre (Barc) 1980 0.75
147 [Normal values of intraerythrocytic 2,3-diphosphoglycerate for the spanish population (author's transl)]. Med Clin (Barc) 1982 0.75
148 Five monoclonal proteins in a patient with chronic myelomonocytic leukemia. Am J Hematol 1992 0.75